Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 159 articles: HTML format

Single Articles

July 2024
1. CHENG A, Holland SM
   Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency. Reply.
   N Engl J Med. 2024;391:189-190.
   PubMed    
   
   
   
2. ROSMARIN D, Amara S, Lebwohl M
   Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
   N Engl J Med. 2024;391:189.
   PubMed    
   
   
   
3. COHEN JM, Damsky W
   Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
   N Engl J Med. 2024;391:188-189.
   PubMed    
   
   
   
4. FEREDJ E, Cobat A, Casanova JL
   Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
   N Engl J Med. 2024;391:187-188.
   PubMed    
   
   
   June 2024
5. MANRIQUE-ACEVEDO C, Hirsch IB, Eckel RH
   Prevention of Cardiovascular Disease in Type 1 Diabetes. Reply.
   N Engl J Med. 2024;390:2227.
   PubMed    
   
   
   
6. MAAHS DM, Svensson J
   Prevention of Cardiovascular Disease in Type 1 Diabetes.
   N Engl J Med. 2024;390:2226-2227.
   PubMed    
   
   
   
7. WENSTEDT EFE, Vogt L
   Prevention of Cardiovascular Disease in Type 1 Diabetes.
   N Engl J Med. 2024;390:2226.
   PubMed    
   
   
   
8. CHEN Y, Xu Y, Li H, Sun T, et al
   A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia.
   N Engl J Med. 2024;390:2178-2190.
   PubMed     Abstract available
   
   
   May 2024
9. WECHSLER ME, Fan Y, Merkel PA
   Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis. Reply.
   N Engl J Med. 2024;390:1940.
   PubMed    
   
   
   
10. SUN R, Wei LJ
    Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2024;390:1939.
    PubMed    
    
    
    
11. OIKONOMOU V, Smith G, Constantine GM, Schmitt MM, et al
    The Role of Interferon-gamma in Autoimmune Polyendocrine Syndrome Type 1.
    N Engl J Med. 2024;390:1873-1884.
    PubMed     Abstract available
    
    
    
12. SU MA
    JAK Inhibition Immunotherapy for APS-1.
    N Engl J Med. 2024;390:1918-1921.
    PubMed    
    
    
    
13. HENGEL FE, Dehde S, Lasse M, Zahner G, et al
    Autoantibodies Targeting Nephrin in Podocytopathies.
    N Engl J Med. 2024 May 25. doi: 10.1056/NEJMoa2314471.
    PubMed     Abstract available
    
    
    
14. WANG JJ, Schonborn L, Warkentin TE, Chataway T, et al
    Antibody Fingerprints Linking Adenoviral Anti-PF4 Disorders.
    N Engl J Med. 2024;390:1827-1829.
    PubMed    
    
    
    
15. DOUGHTY CT, Schaefer PW, Brizzi K, Linnoila JJ, et al
    Case 14-2024: A 30-Year-Old Woman with Back Pain, Leg Stiffness, and Falls.
    N Engl J Med. 2024;390:1712-1719.
    PubMed    
    
    
    
16. MULLER F, Mackensen A, Schett G
    CAR T-Cell Therapy in Autoimmune Disease. Reply.
    N Engl J Med. 2024;390:1631-1632.
    PubMed    
    
    
    
17. HOWARD JF JR, Vu T, Mozaffar T
    CAR T-Cell Therapy in Autoimmune Disease.
    N Engl J Med. 2024;390:1629-1631.
    PubMed    
    
    
    
18. DE BENEDETTI F, Diomedi Camassei F, Locatelli F
    CAR T-Cell Therapy in Autoimmune Disease.
    N Engl J Med. 2024;390:1629.
    PubMed    
    
    
    
19. MERKT W, Lorenz HM, Schmitt M
    CAR T-Cell Therapy in Autoimmune Disease.
    N Engl J Med. 2024;390:1628-1629.
    PubMed    
    
    
    April 2024
20. MATHUR M, Barratt J, Suzuki Y
    Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy. Reply.
    N Engl J Med. 2024;390:1245-1246.
    PubMed    
    
    
    
21. BELMONT HM
    Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
    N Engl J Med. 2024;390:1245.
    PubMed    
    
    
    
22. MANRIQUE-ACEVEDO C, Hirsch IB, Eckel RH
    Prevention of Cardiovascular Disease in Type 1 Diabetes.
    N Engl J Med. 2024;390:1207-1217.
    PubMed    
    
    
    March 2024
23. NETEA MG, van de Veerdonk FL
    Anti-Interleukin-23 Autoantibodies and Severe Infections.
    N Engl J Med. 2024;390:1143-1146.
    PubMed    
    
    
    
24. CHENG A, Kashyap A, Salvator H, Rosen LB, et al
    Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
    N Engl J Med. 2024;390:1105-1117.
    PubMed     Abstract available
    
    
    
25. DRIVENES JL, Bygum A
    Spontaneous Oral Purpura in Immune Thrombocytopenia.
    N Engl J Med. 2024;390:1029.
    PubMed    
    
    
    
26. WECHSLER ME, Nair P, Terrier B, Walz B, et al
    Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
    N Engl J Med. 2024;390:911-921.
    PubMed     Abstract available
    
    
    February 2024
27. MULLER F, Taubmann J, Bucci L, Wilhelm A, et al
    CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.
    N Engl J Med. 2024;390:687-700.
    PubMed     Abstract available
    
    
    
28. ISAACS JD
    CAR T Cells - A New Horizon for Autoimmunity?
    N Engl J Med. 2024;390:758-759.
    PubMed    
    
    
    
29. HAUSER SL
    Silencing Immune Dialogue in Multiple Sclerosis.
    N Engl J Med. 2024;390:662-663.
    PubMed    
    
    
    
30. VERMERSCH P, Granziera C, Mao-Draayer Y, Cutter G, et al
    Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
    N Engl J Med. 2024;390:589-600.
    PubMed     Abstract available
    
    
    January 2024
31. DANDONA P, Chaudhuri A, Ghanim H
    More on Semaglutide in Early Type 1 Diabetes. Reply.
    N Engl J Med. 2024;390:292.
    PubMed    
    
    
    
32. GAGLIA JL, Laffel LM, Patti ME
    More on Semaglutide in Early Type 1 Diabetes.
    N Engl J Med. 2024;390:291.
    PubMed    
    
    
    
33. WEINRAUCH LA, D'Elia JA
    More on Semaglutide in Early Type 1 Diabetes.
    N Engl J Med. 2024;390:291.
    PubMed    
    
    
    
34. DEVRIES JH
    More on Semaglutide in Early Type 1 Diabetes.
    N Engl J Med. 2024;390:290.
    PubMed    
    
    
    
35. HADZIC N, Deheragoda M, Worth A, Bansal S, et al
    JAK Inhibition in STAT1 Gain-of-Function-Mediated Treatment-Resistant Autoimmune Hepatitis.
    N Engl J Med. 2024;390:284-286.
    PubMed    
    
    
    
36. LEE TTM, Bergford S, Murphy HR
    Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes. Reply.
    N Engl J Med. 2024;390:184.
    PubMed    
    
    
    
37. GRZYCH G, Kim I
    Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes.
    N Engl J Med. 2024;390:183-184.
    PubMed    
    
    
    
38. VIVANTI AJ, Benachi A, Voican A
    Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes.
    N Engl J Med. 2024;390:183.
    PubMed    
    
    
    
39. LEMLEY KV, Glassock RJ
    APRIL - Springtime for New IgA Nephropathy Therapy?
    N Engl J Med. 2024;390:80-81.
    PubMed    
    
    
    
40. LIU MJ, Li J
    Necrobiosis Lipoidica.
    N Engl J Med. 2024;390:70.
    PubMed    
    
    
    December 2023
41. ARJUNAN D, Bhadada SK
    Thyroid Dermopathy in Graves' Disease.
    N Engl J Med. 2023;389:2376.
    PubMed    
    
    
    
42. LUDVIGSSON J
    Immune Interventions at Onset of Type 1 Diabetes - Finally, a Bit of Hope.
    N Engl J Med. 2023;389:2199-2201.
    PubMed    
    
    
    
43. WAIBEL M, Wentworth JM, So M, Couper JJ, et al
    Baricitinib and beta-Cell Function in Patients with New-Onset Type 1 Diabetes.
    N Engl J Med. 2023;389:2140-2150.
    PubMed     Abstract available
    
    
    November 2023
44. EL-ZAATARI ZM
    Anti-Glomerular Basement Membrane Glomerulonephritis.
    N Engl J Med. 2023;389:1901.
    PubMed    
    
    
    
45. BUSSEL JB, Hou M, Cines DB
    Primary Immune Thrombocytopenia in Pregnancy. Reply.
    N Engl J Med. 2023;389:1728.
    PubMed    
    
    
    
46. TRAN BW, May KA, Pal N
    Primary Immune Thrombocytopenia in Pregnancy.
    N Engl J Med. 2023;389:1728.
    PubMed    
    
    
    
47. MATHUR M, Barratt J, Chacko B, Chan TM, et al
    A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
    N Engl J Med. 2023 Nov 2. doi: 10.1056/NEJMoa2305635.
    PubMed     Abstract available
    
    
    October 2023
48. RAMOS EL, Dayan CM, Chatenoud L, Sumnik Z, et al
    Teplizumab and beta-Cell Function in Newly Diagnosed Type 1 Diabetes.
    N Engl J Med. 2023 Oct 18. doi: 10.1056/NEJMoa2308743.
    PubMed     Abstract available
    
    
    
49. LINDHOFF-LAST E, Schonborn L, Zaninetti C, Warkentin TE, et al
    Rescue Therapy in Chronic Prothrombotic Autoimmune Anti-PF4 Disorder.
    N Engl J Med. 2023;389:1339-1341.
    PubMed    
    
    
    
50. SPIERA RF, Unizony S, Warrington KJ, Sloane J, et al
    Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
    N Engl J Med. 2023;389:1263-1272.
    PubMed     Abstract available
    
    
    
51. LEE TTM, Collett C, Bergford S, Hartnell S, et al
    Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes.
    N Engl J Med. 2023 Oct 5. doi: 10.1056/NEJMoa2303911.
    PubMed     Abstract available
    
    
    
52. GARG SK, Polsky S
    Technology Use and Glycemic Outcomes during Pregnancy with Type 1 Diabetes.
    N Engl J Med. 2023 Oct 5. doi: 10.1056/NEJMe2310798.
    PubMed    
    
    
    
53. ALETAHA D
    Polymyalgia Rheumatica - from Search for Efficacy to Choice of Strategy.
    N Engl J Med. 2023;389:1328-1329.
    PubMed    
    
    
    September 2023
54. BRODERICK L, Kastner DL
    Variant STAT4 and Treatment of an Autoinflammatory Syndrome. Reply.
    N Engl J Med. 2023;389:1151-1152.
    PubMed    
    
    
    
55. PASTORE S, De Martino E, Taddio A
    Variant STAT4 and Treatment of an Autoinflammatory Syndrome.
    N Engl J Med. 2023;389:1151.
    PubMed    
    
    
    
56. WANG WY, Cheng ST
    Sleeve Sign and Inverse Gottron's Papules in Anti-MDA5 Dermatomyositis.
    N Engl J Med. 2023;389:1032.
    PubMed    
    
    
    
57. DANDONA P, Chaudhuri A, Ghanim H
    Semaglutide in Early Type 1 Diabetes.
    N Engl J Med. 2023;389:958-959.
    PubMed    
    
    
    August 2023
58. FUKUSHIMA H, Matsumoto M
    Cold Agglutinin Syndrome.
    N Engl J Med. 2023;389:642.
    PubMed    
    
    
    
59. BUSSEL JB, Hou M, Cines DB
    Management of Primary Immune Thrombocytopenia in Pregnancy.
    N Engl J Med. 2023;389:540-548.
    PubMed    
    
    
    
60. WARKENTIN TE, Baskin-Miller J, Raybould AL, Sheppard JI, et al
    Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies.
    N Engl J Med. 2023;389:574-577.
    PubMed    
    
    
    
61. KRISCHER JP, Lernmark A, Hagopian WA, Rewers MJ, et al
    SARS-CoV-2 - No Increased Islet Autoimmunity or Type 1 Diabetes in Teens.
    N Engl J Med. 2023;389:474-475.
    PubMed    
    
    
    
62. KOOSHESH KA, Foy BH, Sykes DB, Gustafsson K, et al
    Health Consequences of Thymus Removal in Adults.
    N Engl J Med. 2023;389:406-417.
    PubMed     Abstract available
    
    
    June 2023
63. WADWA RP, Beck RW, Breton MD
    Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes. Reply.
    N Engl J Med. 2023;388:2206-2207.
    PubMed    
    
    
    
64. SHIBUE K
    Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
    N Engl J Med. 2023;388:2206.
    PubMed    
    
    
    
65. HSU NC, Hsu CH
    Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
    N Engl J Med. 2023;388:2205-2206.
    PubMed    
    
    
    
66. LEE CD, Galetta SL, Dobson R
    Management of Possible Multiple Sclerosis.
    N Engl J Med. 2023;388:2195-2198.
    PubMed    
    
    
    May 2023
67. BAGHDASSARIAN H, Blackstone SA, Clay OS, Philips R, et al
    Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome.
    N Engl J Med. 2023 May 31. doi: 10.1056/NEJMoa2202318.
    PubMed     Abstract available
    
    
    April 2023
68. CONNOLLY CM, Christopher-Stine L
    Periorbital Edema in Dermatomyositis.
    N Engl J Med. 2023;388:e52.
    PubMed    
    
    
    March 2023
69. BRUTTOMESSO D
    Technology in the Changing Management of Diabetes in Children.
    N Engl J Med. 2023;388:1052-1054.
    PubMed    
    
    
    
70. LEE AI, Heidari P, Fenves AZ, Bardia A, et al
    Case 8-2023: A 71-Year-Old Woman with Refractory Hemolytic Anemia.
    N Engl J Med. 2023;388:1032-1041.
    PubMed    
    
    
    
71. WADWA RP, Reed ZW, Buckingham BA, DeBoer MD, et al
    Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes.
    N Engl J Med. 2023;388:991-1001.
    PubMed     Abstract available
    
    
    January 2023
72. RUSSELL SJ, Damiano ER, Calhoun P
    Randomized Trial of a Bionic Pancreas in Type 1 Diabetes. Reply.
    N Engl J Med. 2023;388:380-382.
    PubMed    
    
    
    
73. KHOO TK
    Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    N Engl J Med. 2023;388:380.
    PubMed    
    
    
    
74. MURATA Y, Takita M, Kami M
    Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    N Engl J Med. 2023;388:380.
    PubMed    
    
    
    
75. AGGARWAL R, Charles-Schoeman C, Schessl J
    Trial of Intravenous Immune Globulin in Dermatomyositis. Reply.
    N Engl J Med. 2023;388:94-95.
    PubMed    
    
    
    
76. WERTH VP, Fiorentino DF, Vleugels RA
    Trial of Intravenous Immune Globulin in Dermatomyositis.
    N Engl J Med. 2023;388:94.
    PubMed    
    
    
    November 2022
77. BURNSIDE MJ, Williman JA, de Bock MI
    Open-Source Automated Insulin Delivery in Type 1 Diabetes. Reply.
    N Engl J Med. 2022;387:2007-2008.
    PubMed    
    
    
    
78. SCARAMUZZA AE, Cherubini V, Rabbone I
    Open-Source Automated Insulin Delivery in Type 1 Diabetes.
    N Engl J Med. 2022;387:2006-2007.
    PubMed    
    
    
    
79. MURATA Y, Takita M, Kami M
    Open-Source Automated Insulin Delivery in Type 1 Diabetes.
    N Engl J Med. 2022;387:2006.
    PubMed    
    
    
    
80. BRENNAN T
    Pharmaceutical Marketing Revisited - United States v. Biogen Idec.
    N Engl J Med. 2022;387:1631-1633.
    PubMed    
    
    
    October 2022
81. WERTH VP, Barbey C, Franchimont N
    Anti-BDCA2 Antibody for Cutaneous Lupus Erythematosus. Reply.
    N Engl J Med. 2022;387:1529.
    PubMed    
    
    
    
82. PSARRAS A, Vital EM
    Anti-BDCA2 Antibody for Cutaneous Lupus Erythematosus.
    N Engl J Med. 2022;387:1528-1529.
    PubMed    
    
    
    
83. REBELLO A, Joshi P
    Giant-Cell Arteritis.
    N Engl J Med. 2022;387:e36.
    PubMed    
    
    
    
84. AMATO AA
    Intravenous Immune Globulin Therapy in Dermatomyositis.
    N Engl J Med. 2022;387:1320-1321.
    PubMed    
    
    
    
85. AGGARWAL R, Charles-Schoeman C, Schessl J, Bata-Csorgo Z, et al
    Trial of Intravenous Immune Globulin in Dermatomyositis.
    N Engl J Med. 2022;387:1264-1278.
    PubMed     Abstract available
    
    
    
86. LEELARATHNA L, Evans ML, Neupane S, Rayman G, et al
    Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes.
    N Engl J Med. 2022 Oct 5. doi: 10.1056/NEJMoa2205650.
    PubMed     Abstract available
    
    
    September 2022
87. RUSSELL SJ, Beck RW, Damiano ER, El-Khatib FH, et al
    Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    N Engl J Med. 2022;387:1161-1172.
    PubMed     Abstract available
    
    
    
88. COLIZZO FP, Shroff SG, High FA, Chen YB, et al
    Case 29-2022: A 33-Year-Old Man with Chronic Diarrhea and Autoimmune Enteropathy.
    N Engl J Med. 2022;387:1124-1134.
    PubMed    
    
    
    
89. HERRERA-COMOGLIO R, Lane S
    Vaccine-Induced Immune Thrombocytopenia and Thrombosis after the Sputnik V Vaccine.
    N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2210813.
    PubMed    
    
    
    
90. FURIE RA, van Vollenhoven RF, Kalunian K, Navarra S, et al
    Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
    N Engl J Med. 2022;387:894-904.
    PubMed     Abstract available
    
    
    
91. BOLINDER J
    CLOuDs Disperse - Top-Notch Glucose Control and Residual C-Peptide Secretion.
    N Engl J Med. 2022;387:937-938.
    PubMed    
    
    
    
92. BOUGHTON CK, Allen JM, Ware J, Wilinska ME, et al
    Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes.
    N Engl J Med. 2022;387:882-893.
    PubMed     Abstract available
    
    
    
93. BURNSIDE MJ, Lewis DM, Crocket HR, Meier RA, et al
    Open-Source Automated Insulin Delivery in Type 1 Diabetes.
    N Engl J Med. 2022;387:869-881.
    PubMed     Abstract available
    
    
    August 2022
94. STEINMAN L, Fox E, Hartung HP, Alvarez E, et al
    Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
    N Engl J Med. 2022;387:704-714.
    PubMed     Abstract available
    
    
    
95. WINGERCHUK DM, Lucchinetti CF
    Neuromyelitis Optica Spectrum Disorder.
    N Engl J Med. 2022;387:631-639.
    PubMed    
    
    
    July 2022
96. WERTH VP, Furie RA, Romero-Diaz J, Navarra S, et al
    Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
    N Engl J Med. 2022;387:321-331.
    PubMed     Abstract available
    
    
    June 2022
97. KUTER DJ
    Rilzabrutinib in Immune Thrombocytopenia. Reply.
    N Engl J Med. 2022;386:2538.
    PubMed    
    
    
    
98. MURAKAMI J, Senoo Y, Tanimoto T
    Rilzabrutinib in Immune Thrombocytopenia.
    N Engl J Med. 2022;386:2537-2538.
    PubMed    
    
    
    
99. SCHONBORN L, Seck SE, Thiele T, Warkentin TE, et al
    SARS-CoV-2 Infection in Patients with a History of VITT.
    N Engl J Med. 2022 Jun 27. doi: 10.1056/NEJMc2206601.
    PubMed    
    
    
    
100. HUANG YM, Lin PH
     IgG4-Related Ophthalmic Disease.
     N Engl J Med. 2022;386:2315.
     PubMed    
     
     
     
101. JEBARAJ A, Lin A
     Sclerokeratitis in Granulomatosis with Polyangiitis.
     N Engl J Med. 2022;386:2221.
     PubMed    
     
     
     April 2022
102. WARE J, Hovorka R
     Closed-Loop Control in Very Young Children with Type 1 Diabetes. Reply.
     N Engl J Med. 2022;386:1482-1483.
     PubMed    
     
     
     
103. RING BL
     Closed-Loop Control in Very Young Children with Type 1 Diabetes.
     N Engl J Med. 2022;386:1482.
     PubMed    
     
     
     
104. MURATA Y, Takita M, Kami M
     Closed-Loop Control in Very Young Children with Type 1 Diabetes.
     N Engl J Med. 2022;386:1482.
     PubMed    
     
     
     
105. KUTER DJ, Efraim M, Mayer J, Trneny M, et al
     Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia.
     N Engl J Med. 2022;386:1421-1431.
     PubMed     Abstract available
     
     
     March 2022
106. SPERLING MA, Laffel LM
     Current Management of Glycemia in Children with Type 1 Diabetes Mellitus.
     N Engl J Med. 2022;386:1155-1164.
     PubMed    
     
     
     
107. COSTENBADER KH
     A New IMiD for Systemic Lupus Erythematosus - Tempering Our Excitement.
     N Engl J Med. 2022;386:1085-1086.
     PubMed    
     
     
     
108. MERRILL JT, Werth VP, Furie R, van Vollenhoven R, et al
     Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus.
     N Engl J Med. 2022;386:1034-1045.
     PubMed     Abstract available
     
     
     January 2022
109. YONG GY, Lim AL
     Eosinophilic Granulomatosis with Polyangiitis.
     N Engl J Med. 2022;386:374.
     PubMed    
     
     
     
110. WARE J, Allen JM, Boughton CK, Wilinska ME, et al
     Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.
     N Engl J Med. 2022;386:209-219.
     PubMed     Abstract available
     
     
     
111. VIDENOVIC A, Babu S, Zhao B, Reda HM, et al
     Case 1-2022: A 67-Year-Old Man with Motor Neuron Disease and Odd Behaviors during Sleep.
     N Engl J Med. 2022;386:173-180.
     PubMed    
     
     
     
112. PAVORD S, Lester W, Hunt BJ
     Clinical Features of VITT. Reply.
     N Engl J Med. 2022;386.
     PubMed    
     
     
     
113. CHITI A
     Clinical Features of VITT.
     N Engl J Med. 2022;386.
     PubMed    
     
     
     December 2021
114. LACY J, Pavord S, Brown KE
     VITT and Second Doses of Covid-19 Vaccine.
     N Engl J Med. 2021 Dec 22. doi: 10.1056/NEJMc2118507.
     PubMed    
     
     
     
115. DILLY B, Bomahou C
     Tongue Necrosis in Giant-Cell Arteritis.
     N Engl J Med. 2021;385:2377.
     PubMed    
     
     
     
116. BRADBURY CA, Hill Q, Greenwood R
     Mycophenolate Mofetil for Immune Thrombocytopenia. Reply.
     N Engl J Med. 2021;385:2201-2202.
     PubMed    
     
     
     
117. VAN DIJK WEM, Schutgens REG
     Mycophenolate Mofetil for Immune Thrombocytopenia.
     N Engl J Med. 2021;385:2201.
     PubMed    
     
     
     
118. GHANIMA W, Zaja F, Michel M
     Mycophenolate Mofetil for Immune Thrombocytopenia.
     N Engl J Med. 2021;385:2200-2201.
     PubMed    
     
     
     
119. CHEN S, Dong C, Wei JC
     Mycophenolate Mofetil for Immune Thrombocytopenia.
     N Engl J Med. 2021;385:2200.
     PubMed    
     
     
     November 2021
120. O'CONNELL J, Nathan DM, O'Brien T, O'Keeffe DT, et al
     Treatment of Diabetes - To Pump or Not to Pump.
     N Engl J Med. 2021;385:2092-2095.
     PubMed    
     
     
     
121. MANDL A, Burbelo PD, Di Pasquale G, Tay YS, et al
     Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor.
     N Engl J Med. 2021;385:1974-1980.
     PubMed     Abstract available
     
     
     
122. BJORNSTAD P, Drews K, Zeitler PS
     Long-Term Complications in Youth-Onset Type 2 Diabetes. Reply.
     N Engl J Med. 2021;385:2016.
     PubMed    
     
     
     
123. NELSON RG, Hanson RL, Knowler WC
     Long-Term Complications in Youth-Onset Type 2 Diabetes.
     N Engl J Med. 2021;385:2015.
     PubMed    
     
     
     
124. YANG W, Wang C
     Long-Term Complications in Youth-Onset Type 2 Diabetes.
     N Engl J Med. 2021;385:2014-2015.
     PubMed    
     
     
     
125. MOUGIAKAKOS D, Kronke G, Schett G
     More on CD19-CAR T Cells in Systemic Lupus Erythematosus. Reply.
     N Engl J Med. 2021;385:e67.
     PubMed    
     
     
     
126. KONIG MF, Paul S
     More on CD19-CAR T Cells in Systemic Lupus Erythematosus.
     N Engl J Med. 2021;385:e67.
     PubMed    
     
     
     
127. SCHONBORN L, Thiele T, Kaderali L, Greinacher A, et al
     Decline in Pathogenic Antibodies over Time in VITT.
     N Engl J Med. 2021;385:1815-1816.
     PubMed    
     
     
     October 2021
128. BERENTSEN S, Barcellini W
     Autoimmune Hemolytic Anemias.
     N Engl J Med. 2021;385:1407-1419.
     PubMed    
     
     
     September 2021
129. MATTHIESEN MI, Shailam R, Rothermel H
     Case 29-2021: A 12-Month-Old Boy with Fever and Developmental Regression.
     N Engl J Med. 2021;385:1220-1229.
     PubMed    
     
     
     
130. TSUI JC, Onishi S
     Symblepharon in Linear IgA Bullous Dermatosis.
     N Engl J Med. 2021;385:1219.
     PubMed    
     
     
     
131. WERTH VP, Joly P, Chen DM
     Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris. Reply.
     N Engl J Med. 2021;385:1056.
     PubMed    
     
     
     
132. HOPKINS ZH, Wu BC, Nousari CH
     Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris.
     N Engl J Med. 2021;385:1055-1056.
     PubMed    
     
     
     
133. BOLTON-MAGGS PHB, George JN
     Immune Thrombocytopenia Treatment.
     N Engl J Med. 2021;385:948-950.
     PubMed    
     
     
     
134. BRADBURY CA, Pell J, Hill Q, Bagot C, et al
     Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia.
     N Engl J Med. 2021;385:885-895.
     PubMed     Abstract available
     
     
     August 2021
135. PAVORD S, Scully M, Hunt BJ, Lester W, et al
     Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
     N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109908.
     PubMed     Abstract available
     
     
     
136. GOYAL RK
     Gastric Emptying Abnormalities in Diabetes Mellitus. Reply.
     N Engl J Med. 2021;385:576.
     PubMed    
     
     
     
137. AKTURK HK, Shah VN
     Gastric Emptying Abnormalities in Diabetes Mellitus.
     N Engl J Med. 2021;385:575-576.
     PubMed    
     
     
     
138. MOUGIAKAKOS D, Kronke G, Volkl S, Kretschmann S, et al
     CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus.
     N Engl J Med. 2021;385:567-569.
     PubMed    
     
     
     July 2021
139. SMIBERT OC, Catalano OA, Goodarzi K, Roberts MB, et al
     Case 23-2021: A 41-Year-Old Woman with Bloody Stools and Thrombocytopenia.
     N Engl J Med. 2021;385:451-460.
     PubMed    
     
     
     
140. KRATKA A, Yozamp N, Vaidya A, Marqusee E, et al
     A Periodic Problem.
     N Engl J Med. 2021;385:e17.
     PubMed    
     
     
     
141. AVELAR RODRIGUEZ D, Orkin J
     An Icteric Tongue.
     N Engl J Med. 2021;385:e16.
     PubMed    
     
     
     
142. MORAN-THOMAS A
     One Hundred Years of Insulin for Some.
     N Engl J Med. 2021;385:293-295.
     PubMed    
     
     
     
143. GOGLIN SE, Margaretten ME
     Malar Rash.
     N Engl J Med. 2021;385:164.
     PubMed    
     
     
     
144. PATRIQUIN CJ, Laroche V, Selby R, Pendergrast J, et al
     Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
     N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2109465.
     PubMed    
     
     
     June 2021
145. O'CONNELL KA, LaChance AH
     Dermatomyositis.
     N Engl J Med. 2021;384:2437.
     PubMed    
     
     
     
146. SEEKER P, Osswald S
     Tongue Discoloration.
     N Engl J Med. 2021;384:e102.
     PubMed    
     
     
     
147. WERTH VP, Joly P, Mimouni D, Maverakis E, et al
     Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.
     N Engl J Med. 2021;384:2295-2305.
     PubMed     Abstract available
     
     
     May 2021
148. JAYNE DRW, Merkel PA, Bekker P
     Avacopan for the Treatment of ANCA-Associated Vasculitis. Reply.
     N Engl J Med. 2021;384:e81.
     PubMed    
     
     
     
149. MATSUO Y, Miyabe Y
     Avacopan for the Treatment of ANCA-Associated Vasculitis.
     N Engl J Med. 2021;384:e81.
     PubMed    
     
     
     
150. CHANDWAR K
     Avacopan for the Treatment of ANCA-Associated Vasculitis.
     N Engl J Med. 2021;384:e81.
     PubMed    
     
     
     
151. BLANCO-DOMINGUEZ R, Sanchez-Diaz R, de la Fuente H, Jimenez-Borreguero LJ, et al
     A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
     N Engl J Med. 2021;384:2014-2027.
     PubMed     Abstract available
     
     
     
152. GIBBONS MD, Mendoza DP, Waheed A, Barshak MB, et al
     Case 14-2021: A 64-Year-Old Woman with Fever and Pancytopenia.
     N Engl J Med. 2021;384:1849-1857.
     PubMed    
     
     
     
153. FRALICK M, Sarma S
     Thyrotoxic Periodic Paralysis.
     N Engl J Med. 2021;384:e71.
     PubMed    
     
     
     
154. MOHAMED F, Raal FJ
     Hyperpigmentation from Addison's Disease.
     N Engl J Med. 2021;384:1752.
     PubMed    
     
     
     April 2021
155. KOREN D, Sparger KA, Shailam R, Sadow PM, et al
     Case 13-2021: A Newborn Girl with a Neck Mass.
     N Engl J Med. 2021;384:1647-1655.
     PubMed    
     
     
     
156. GREINACHER A, Thiele T, Warkentin TE, Weisser K, et al
     Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
     N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104840.
     PubMed     Abstract available
     
     
     
157. SCHULTZ NH, Sorvoll IH, Michelsen AE, Munthe LA, et al
     Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
     N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104882.
     PubMed     Abstract available
     
     
     
158. ROTH A, Barcellini W, D'Sa S, Miyakawa Y, et al
     Sutimlimab in Cold Agglutinin Disease.
     N Engl J Med. 2021;384:1323-1334.
     PubMed     Abstract available
     
     
     
159. ZONOZI R, Niles JL
     Sunken Nose.
     N Engl J Med. 2021;384:e52.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.